Interestingly, 16S-high regions in glioma, but not BrM, showed upregulation of chromatin remodeling proteins, suggesting distinct host responses to bacterial signals in primary versus metastatic brain tumors. The gene discussed is SMARCA2; the disease is central nervous system cancer.